Literature DB >> 18343482

Clk-1 deficiency induces apoptosis associated with mitochondrial dysfunction in mouse embryos.

Mayumi Takahashi1, Takahiko Shimizu, Eiko Moriizumi, Takuji Shirasawa.   

Abstract

Clk-1 gene encodes demethoxyubiquinone hydroxylase that catalyzes the production of coenzyme Q (CoQ) in mitochondria. Clk-1-deficient mice that lack CoQ fail to survive beyond the embryonic day 10.5 (E10.5). However, the relationship between the clk-1-deficiency and embryonic lethality remains unclear. We show in this study that TUNEL-positive cells are frequently observed in whole bodies of clk-1-deficient mouse embryos at E10.5. In addition, dissociated cells from the embryos exhibited characteristic features of apoptosis, such as externalization of phosphatidylserine on the plasma membrane, caspase-3 activation, and the release of cytochrome c from mitochondria into the cytoplasm, as the first sign of mitochondria-mediated apoptosis. In embryonic cells, the mitochondrial functions such as maintenance of the mitochondrial membrane potential and intracellular ATP level were impaired. Since exogenous CoQ10 rescued the mitochondrial dysfunction and suppressed apoptosis in clk-1-deficient cells, we propose that clk-1-deficiency induces apoptosis associated with mitochondrial dysfunction due to a lack of CoQ, which may lead to embryonic lethality in mice around E10.5.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343482     DOI: 10.1016/j.mad.2008.01.008

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  8 in total

1.  Early mitochondrial dysfunction in long-lived Mclk1+/- mice.

Authors:  Jérôme Lapointe; Siegfried Hekimi
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

2.  Invertebrate models for coenzyme q10 deficiency.

Authors:  Daniel J M Fernández-Ayala; Sandra Jiménez-Gancedo; Ignacio Guerra; Plácido Navas
Journal:  Mol Syndromol       Date:  2014-07

3.  Restoring de novo coenzyme Q biosynthesis in Caenorhabditis elegans coq-3 mutants yields profound rescue compared to exogenous coenzyme Q supplementation.

Authors:  Fernando Gomez; Ryoichi Saiki; Randall Chin; Chandra Srinivasan; Catherine F Clarke
Journal:  Gene       Date:  2012-06-23       Impact factor: 3.688

4.  Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects.

Authors:  Luis C López; Catarina M Quinzii; Estela Area; Ali Naini; Shamima Rahman; Markus Schuelke; Leonardo Salviati; Salvatore Dimauro; Michio Hirano
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

5.  Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.

Authors:  Lucia V Schottlaender; Conceição Bettencourt; Aoife P Kiely; Annapurna Chalasani; Viruna Neergheen; Janice L Holton; Iain Hargreaves; Henry Houlden
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

Review 6.  Water-soluble CoQ10 as A Promising Anti-aging Agent for Neurological Dysfunction in Brain Mitochondria.

Authors:  Mayumi Takahashi; Kazuhide Takahashi
Journal:  Antioxidants (Basel)       Date:  2019-03-11

7.  TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.

Authors:  Adrien Daigeler; Christina Brenzel; Daniel Bulut; Anne Geisler; Christoph Hilgert; Marcus Lehnhardt; Hans U Steinau; Annegret Flier; Lars Steinstraesser; Ludger Klein-Hitpass; Ulrich Mittelkötter; Waldemar Uhl; Ansgar M Chromik
Journal:  J Exp Clin Cancer Res       Date:  2008-12-12

Review 8.  The Paradox of Coenzyme Q10 in Aging.

Authors:  M Elena Díaz-Casado; José L Quiles; Eliana Barriocanal-Casado; Pilar González-García; Maurizio Battino; Luis C López; Alfonso Varela-López
Journal:  Nutrients       Date:  2019-09-14       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.